Category: Events

Join us at #Sachs_BEF

🔬 Dive into the future of cancer treatment! Join us on the 21st of September, 2023 for the ‘Advances in Immuno-Oncology’ panel at the 23rd Annual Biotech in Europe Forum (#Sachs_BEF) 🌍 Mark your calendar and learn about the latest breakthroughs in immuno-oncology from leading industry experts! 📆🎗️ Co-Chaired by: Esteban Pombo-Villar, CTO, TargImmune Therapeutics AG Ekaterina Smirnyagina Smirnyagina, Senior Partner (Life Sciences), Oxford Science Enterprises Panellists: Luc Boblet Co-Founder & CEO, Egle Therapeutics SAS Pascal Winnen Neuville, CEO, DOMAIN Therapeutics SA Paul Bravetti, CEO, Brenus Pharma Per NorlĂ©n, CEO, Evaxion Biotech A/S

INCREASE IMMUNOGENICITY

Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system  with visible and multi-specific targets

More about Haptenization & STC immunogenicity
Back to the page

REPRESENT HETEROGENEITY OF THE TARGETED INDICATION

Selection criteria of starting material (Allogeneic tumor cell lines)

  • Representative oncogenic drivers (TP53,BRAF,KRAS,…)
  • Cold & hot tumor cell lines
  • Resistances capacities (metabolic ; chemical & physical)
Back to the page

Increase antigenicity

Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system  with a broad & higher quality range of tumor antigens

More about STC Antigenicity
Back to the page